scispace - formally typeset
Journal ArticleDOI

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

D.M. Harnois
- 01 Jan 2010 - 
- Vol. 2010, pp 233-234
About
This article is published in Yearbook of Gastroenterology.The article was published on 2010-01-01. It has received 584 citations till now. The article focuses on the topics: Hepatitis C virus.

read more

Citations
More filters
Journal ArticleDOI

Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?

TL;DR: If the problem of the high cost is overcome, interferon-free therapies will lead to what has long been a chimera, namely, an HCV-free world.
Journal ArticleDOI

Molecular Functions of Thyroid Hormones and Their Clinical Significance in Liver-Related Diseases

TL;DR: Recent studies focusing on the roles of THs and TRs in several disorders, in particular, liver diseases are reviewed and the potential therapeutic applications ofTHs and underlying molecular mechanisms are discussed.
Journal ArticleDOI

Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.

TL;DR: Careful management of diabetes in patients with liver disease may reduce the risk of clinical decompensation in this population of working-aged insured patients dually diagnosed with compensated cirrhosis and diabetes.
Journal ArticleDOI

Obeticholic acid for the treatment of primary biliary cholangitis

TL;DR: Obeticholic acid (OCA, 6-ECDCA, or INT-747), a first-in-class FXR agonist, has been examined in PBC patients with inadequate response to UDCA, and shown promising results, particularly on reduction of serum alkaline phosphatase (ALP, an important prognostic marker in P BC).
References
More filters
Journal ArticleDOI

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

TL;DR: Prevalence of hepatitis C cirrhosis and its complications will continue to increase through the next decade and will mostly affect those older than 60 years of age, but wider application of antiviral treatment and better responses with new agents could significantly reduce the impact of this disease in coming years.
Related Papers (5)